MSP Recovery (MSPR)
OTHER OTC:MSPR
Top Page
MSP Recovery
(OTC:MSPR)
Select Model
Select Model
Rating:40Underperform
Price Target:
$0.05
▼(-81.92% Downside)
Action:ReiteratedDate:01/31/26
The score is driven primarily by severe financial weakness (declining revenue, large losses, negative cash flows, and negative equity). Technicals also remain bearish with price below key moving averages and a negative MACD. Corporate events add additional near-term risk due to delisting and constrained, discretionary liquidity support, while valuation metrics provided offer limited positive support.
Positive Factors
Contingency fee business model
MSPR's contingency fee model aligns revenue with client recoveries, reducing reliance on fixed billing and shifting collection risk to performance. Over 2-6 months this model supports cash conversion when recoveries occur and incentivizes client retention and scalable growth tied to recovery effectiveness.
Negative Factors
Severe financial deterioration
Steep revenue decline, deeply negative margins and recurring negative cash flow indicate structural operating weakness and poor cash generation. Over a multi-month horizon this erodes liquidity, restricts reinvestment and increases likelihood the firm must secure dilutive or costly financing to sustain operations.
Read all positive and negative factors
Positive Factors
Negative Factors
Contingency fee business model
MSPR's contingency fee model aligns revenue with client recoveries, reducing reliance on fixed billing and shifting collection risk to performance. Over 2-6 months this model supports cash conversion when recoveries occur and incentivizes client retention and scalable growth tied to recovery effectiveness.
Read all positive factors
MSP Recovery (MSPR) vs. SPDR S&P 500 ETF (SPY)
Market Cap
$411.80K
Dividend YieldN/A
Average Volume (3M)1.26M
Price to Earnings (P/E)―
Beta (1Y)0.82
Revenue Growth-8.57%
EPS Growth-52.17%
CountryUS
Employees78
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-132.71
Shares Outstanding13,774,399
10 Day Avg. Volume629,537
30 Day Avg. Volume1,256,259
Financial Highlights & Ratios
PEG Ratio>-0.01
Price to Book (P/B)0.16
Price to Sales (P/S)0.87
P/FCF Ratio-0.96
Enterprise Value/Market Cap1.85K
Enterprise Value/Revenue77.45
Enterprise Value/Gross Profit294.14
Enterprise Value/Ebitda-1.23
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
MSP Recovery Business Overview & Revenue Model
Company Description
MSP Recovery (MSPR) is a healthcare and technology company specializing in the recovery of secondary payments for healthcare providers and insurers. The company focuses on identifying and recovering funds that are owed to healthcare providers unde...
How the Company Makes Money
MSP Recovery generates revenue through a contingency fee model, whereby it earns a percentage of the recovered funds on behalf of its clients. This means that the company only makes money when it successfully recovers payments, aligning its financ...
MSP Recovery Earnings Call Summary
Earnings Call Date:May 15, 2024
(Q1-2024)
| % Change Since: |
Next Earnings Date:Apr 22, 2026
Earnings Call Sentiment Neutral
The earnings call highlighted LifeWallet's successful settlements and increased claims recovery income, demonstrating progress in its core business model. However, the company also reported a significant operating loss, primarily due to noncash items. Overall, while there are substantial achievements, the financial results reflect ongoing challenges.Positive Updates
Successful Settlements with Insurers
LifeWallet achieved two comprehensive settlements with multiple property and casualty insurers, resolving claims and establishing a process for future claims. The settlements include provisions for data sharing and a 5-year agreement for binding mediation of Medicare claim liens.
Negative Updates
Significant Operating Loss
LifeWallet reported an operating loss of $130 million for Q1 2024, with 93% attributed to noncash items such as claims amortization expense.
Read all updates
Q1-2024 Updates
Positive
Negative
Successful Settlements with Insurers
LifeWallet achieved two comprehensive settlements with multiple property and casualty insurers, resolving claims and establishing a process for future claims. The settlements include provisions for data sharing and a 5-year agreement for binding mediation of Medicare claim liens.
Read all positive updates
Company Guidance
During the LifeWallet First Quarter 2024 earnings call, the company provided guidance highlighting significant achievements and financial metrics. LifeWallet reached two comprehensive settlements with property and casualty insurers, which included agreements to provide 10 years of historical data and to collaboratively resolve future Medicare claims. These settlements resulted in claims recovery income of $6 million for Q1 2024, an increase from the $3.5 million reported in Q1 2023. The company reported a total operating loss of $130 million, primarily driven by non-cash items, with an adjusted operating loss of $8.7 million after excluding claims amortization expenses. LifeWallet's total assets were valued at $3 billion, with liabilities amounting to $1.8 billion. The company has extended various obligations to 2025 and secured additional liquidity through a working capital credit facility and a Yorkville standby equity purchase agreement, ensuring its ability to meet cash obligations over the next year.MSP Recovery Financial Statement Overview
Summary
Income Statement
25
Negative
Balance Sheet
30
Negative
Cash Flow
20
Very Negative
| Breakdown | TTM | Mar 2025 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 9.81M | 18.25M | 7.71M | 23.42M | 14.63M | 13.89M |
| Gross Profit | 2.58M | 8.64M | 5.56M | 21.37M | 14.09M | 13.71M |
| EBITDA | -617.81M | -652.46M | -545.71M | -280.47M | -5.52M | -3.15M |
| Net Income | -719.22M | -360.50M | -56.35M | -7.42M | -33.09M | -24.25M |
Balance Sheet | ||||||
| Total Assets | 1.55B | 1.92B | 3.16B | 3.42B | 104.01M | 17.84M |
| Cash, Cash Equivalents and Short-Term Investments | 1.82M | 12.33M | 11.63M | 3.66M | 1.66M | 11.88M |
| Total Debt | 761.48M | 794.66M | 679.22M | 324.25M | 213.61M | 48.09M |
| Total Liabilities | 2.40B | 2.05B | 1.74B | 1.23B | 255.41M | 133.69M |
| Stockholders Equity | -563.84M | 100.58M | 272.39M | 109.69M | -155.76M | -120.18M |
Cash Flow | ||||||
| Free Cash Flow | -10.59M | -16.65M | -41.77M | -83.62M | 1.62M | -344.00K |
| Operating Cash Flow | -10.22M | -16.12M | -40.02M | -80.64M | 2.25M | -14.00K |
| Investing Cash Flow | -527.00K | -2.73M | 7.56M | -5.68M | -2.01M | 986.00K |
| Financing Cash Flow | 14.93M | 19.54M | 29.02M | 99.73M | -10.46M | 9.61M |
MSP Recovery Technical Analysis
Negative
0.26
Price Trends
0.04
Negative
0.14
Negative
1.96
Negative
Market Momentum
>-0.01
Negative
43.47
Neutral
25.00
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For MSPR, the sentiment is Negative. The current price of 0.26 is above the 20-day moving average (MA) of 0.03, above the 50-day MA of 0.04, and below the 200-day MA of 1.96, indicating a bearish trend. The MACD of >-0.01 indicates Negative momentum. The RSI at 43.47 is Neutral, neither overbought nor oversold. The STOCH value of 25.00 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for MSPR.
MSP Recovery Risk Analysis
MSP Recovery disclosed 95 risk factors in its most recent earnings report. MSP Recovery reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks
MSP Recovery Peers Comparison
UnderperformOutperform
Sector (51)
MSPR
MSP Recovery
0.03
-9.35
-99.70%
WORX
SCWorx
0.12
-0.67
-84.42%
ONMD
OneMedNet
0.95
0.41
76.30%
FOXO
FOXO Technologies
0.01
-2.75
-99.64%
VSEE
VSee Health
0.24
-0.86
-78.55%
ACON
Aclarion, Inc.
3.41
-4.61
-57.48%
MSP Recovery Corporate Events
Business Operations and StrategyPrivate Placements and Financing
MSP Recovery Secures One-Time Discretionary Operating Capital Advance
Negative
Jan 27, 2026
On January 26, 2026, MSP Recovery, Inc., through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC, the administrative agent and lender under its existing working capital credit facility, for a one-time discretiona...
Business Operations and StrategyFinancial DisclosuresPrivate Placements and Financing
MSP Recovery receives discretionary one-time operating expense advance
Negative
Jan 22, 2026
On January 19, 2026, MSP Recovery, Inc., through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC, the administrative agent and lender under its existing working capital credit facility, for a one-time $300,000 ad...
Delistings and Listing ChangesPrivate Placements and Financing
MSP Recovery Gains Extension on Yorkville Financing Default
Negative
Jan 9, 2026
MSP Recovery, Inc. previously entered into a standby equity purchase agreement with Yorkville, under which it can sell up to $250 million of common stock and has received capital advances via convertible promissory notes, with about $3.6 million o...
Business Operations and StrategyPrivate Placements and Financing
MSP Recovery obtains limited one-time advance amid liquidity strain
Negative
Jan 7, 2026
On January 7, 2026, MSP Recovery, Inc., through its subsidiaries, entered into a letter agreement with Hazel Partners Holdings LLC to secure a one-time $325,000 advance under its existing working capital credit facility, with the funds restricted ...
Business Operations and StrategyDelistings and Listing Changes
MSP Recovery Faces OTC Transfer and Liquidity Challenges
Negative
Jan 5, 2026
On December 22, 2025, MSP Recovery, Inc.’s Class A common stock was delisted from the Nasdaq Capital Market, with its common stock and public warrants beginning to trade that day on the OTCQB Venture Market, while its new warrants moved to t...
Executive/Board Changes
MSP Recovery Announces Transition of Chief Operating Officer
Neutral
Dec 29, 2025
On December 22, 2025, MSP Recovery, Inc. announced that Ricardo Rivera ceased to be employed by the company and no longer serves as Chief Operating Officer, though he will remain available to advise the company through December 31, 2025 to support...
Delistings and Listing ChangesFinancial DisclosuresRegulatory Filings and Compliance
MSP Recovery Set for Nasdaq Delisting, Moves to OTCQB
Negative
Dec 22, 2025
MSP Recovery, listed under the ticker “MSPR,” operates in the financial and legal services space focused on recovering funds on behalf of healthcare payers and other stakeholders, and its shares have been trading on the Nasdaq Capital ...
Legal ProceedingsRegulatory Filings and Compliance
MSP Recovery Cleared by SEC After Investigation
Positive
Dec 8, 2025
On December 7, 2025, MSP Recovery, Inc. announced that the SEC concluded its investigation without recommending enforcement action against the company or its officers. The investigation, which began on August 11, 2022, focused on various aspects i...
Delistings and Listing ChangesRegulatory Filings and Compliance
MSP Recovery Faces Nasdaq Delisting Threat
Negative
Dec 4, 2025
On October 22, 2025, MSP Recovery received a Staff Delisting Determination from Nasdaq due to non-compliance with the minimum stockholders’ equity requirement and other financial standards. The company has requested a review and submitted ne...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.